8/10/2017 | CVLM | Spectranetics holders may put, convert 2.625% notes due to merger
|
6/28/2017 | CV | Market Commentary: Spectranetics flies higher on takeover news; Microchip busy, but steady; EZCorp on deck
|
6/28/2017 | CV | Market Commentary: Morning Commentary: Spectranetics being bought by Philips, convertibles fly higher; Microchip eyed
|
6/9/2017 | BK | Spectranetics lifts term loan, revolver to $140 million, extends terms
|
2/24/2017 | CV | Market Commentary: Microchip turns around in tandem with underlying shares as broader market reverses course
|
12/7/2015 | BK | Spectranetics signs five-year, $110 million agreement in two tranches
|
7/24/2015 | PP | Market Commentary: Spectranetics flat to better on swap after warning; Iconix comes in; Cobalt in upper 60s
|
7/24/2015 | CV | Market Commentary: Spectranetics flat to better on swap after warning; Iconix comes in; Cobalt in upper 60s
|
7/23/2015 | CV | Market Commentary: New Pattern Energy slips on swap; SanDisk mixed on earnings; Europe brings two new deals
|
5/4/2015 | CV | Market Commentary: New Source launches; Isis adds on swap; Ares Capital steady to mixed after earnings miss
|
4/24/2015 | PP | Market Commentary: Spectranetics gains on swap after quarterly loss; new Cinedigm trades at 101 to 103
|
4/24/2015 | CV | Market Commentary: Spectranetics gains on swap after quarterly loss; new Cinedigm trades at 101 to 103
|
6/30/2014 | PP | Market Commentary: Planned Starwood Waypoint ‘okay’ ahead of pricing; Sprit Realty unchanged, Spectranetics adds on hedge
|
6/30/2014 | CV | Market Commentary: Planned Starwood Waypoint ‘okay’ ahead of pricing; Sprit Realty unchanged, Spectranetics adds on hedge
|
6/30/2014 | CV | Market Commentary: Morning commentary: Starwood Waypoint launches deal; Sprit Realty unchanged on hedge
|
6/5/2014 | CV | Market Commentary: SunEdison expands 2-3 points on hedge; Illumina sells upsized $1 billion deal; some selling
|
6/3/2014 | CV | Spectranetics greenshoe increases 2.625% convertibles to $230 million
|
5/30/2014 | CV | Market Commentary: Midday Commentary: New Renewable Energy higher despite stock decline; Spectranetics adds with shares
|
5/30/2014 | CV | Market Commentary: Renewable Energy up despite lower shares; Spectranetics adds with stock; traders mark month end
|
5/29/2014 | CV | Market Commentary: Midday Commentary: New Spectranetics trades up, New Mountain quiet; Renewable Energy looks cheap
|
5/29/2014 | CV | Market Commentary: New Spectranetics expands 4 points on hedge; New Mountain quiet; Renewable Energy looks cheap
|
5/28/2014 | CV | Market Commentary: Midday Commentary: Planned Spectranetics deal looks cheap; planned New Mountain models a tad rich
|
5/28/2014 | CV | New Issue: Spectranetics prices $200 million 20-year convertibles to yield 2.625%, up 40%
|
5/28/2014 | CV | Market Commentary: Spectranetics, New Mountain price; Spectranetics seen cheap ahead of terms; Newmont Bs ease
|
5/27/2014 | CV | Market Commentary: Convertibles quiet; Workday up with shares before earnings; Spectranetics, New Mountain to price
|
5/27/2014 | CV | Spectranetics to price $200 million convertibles to yield 2.75%-3.25%, up 32.5%-37.5%
|
7/20/2006 | BT | Spectranetics enrolls first patient in above-the-knee arterial-blockage study
|
5/18/2006 | BT | Spectranetics to collaborate on combining imaging technology with laser devices
|
5/9/2006 | BT | Spectranetics greenshoe exercised, raising follow-on offering to $51.75 million
|
5/4/2006 | BT | New Issue: Spectranetics prices $45 million follow-on offering at $12.50
|
4/28/2006 | BT | Market Commentary: Neurocrine drops as data digested; Somaxon higher as buyers step in; Spectranetics up; Sonus soars 8%
|
4/19/2006 | BT | Spectranetics plans follow-on stock sale to raise up to $50 million; posts 1Q loss versus year-ago profit
|
4/19/2006 | BT | Market Commentary: Genzyme crashes on miss; Nektar dips, ends higher; MannKind off; Icon better; Nabi adds another 4%
|
2/8/2006 | BT | Spectranetics: Laser angioplasty trial showed limb salvage rate of 93%
|